ACADIA Pharmaceuticals Inc (ACAD)
16.20
-0.08
(-0.46%)
USD |
NASDAQ |
Nov 21, 16:00
16.20
0.00 (0.00%)
After-Hours: 19:51
ACADIA Pharmaceuticals Price to Book Value: 4.669 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.690 |
| November 19, 2024 | 4.673 |
| November 18, 2024 | 4.910 |
| November 15, 2024 | 4.834 |
| November 14, 2024 | 4.907 |
| November 13, 2024 | 5.071 |
| November 12, 2024 | 5.169 |
| November 11, 2024 | 5.267 |
| November 08, 2024 | 5.091 |
| November 07, 2024 | 4.958 |
| November 06, 2024 | 4.552 |
| November 05, 2024 | 4.324 |
| November 04, 2024 | 4.215 |
| November 01, 2024 | 4.270 |
| October 31, 2024 | 4.206 |
| October 30, 2024 | 4.258 |
| October 29, 2024 | 4.249 |
| October 28, 2024 | 4.248 |
| October 25, 2024 | 4.133 |
| October 24, 2024 | 4.173 |
| October 23, 2024 | 4.119 |
| October 22, 2024 | 4.185 |
| October 21, 2024 | 4.254 |
| October 18, 2024 | 4.410 |
| October 17, 2024 | 4.372 |
| Date | Value |
|---|---|
| October 16, 2024 | 4.335 |
| October 15, 2024 | 4.297 |
| October 14, 2024 | 4.320 |
| October 11, 2024 | 4.300 |
| October 10, 2024 | 4.194 |
| October 09, 2024 | 4.205 |
| October 08, 2024 | 4.168 |
| October 07, 2024 | 4.245 |
| October 04, 2024 | 4.352 |
| October 03, 2024 | 4.242 |
| October 02, 2024 | 4.361 |
| October 01, 2024 | 4.410 |
| September 30, 2024 | 4.433 |
| September 27, 2024 | 5.037 |
| September 26, 2024 | 4.970 |
| September 25, 2024 | 4.918 |
| September 24, 2024 | 5.085 |
| September 23, 2024 | 5.230 |
| September 20, 2024 | 5.307 |
| September 19, 2024 | 5.271 |
| September 18, 2024 | 5.242 |
| September 17, 2024 | 5.220 |
| September 16, 2024 | 5.181 |
| September 13, 2024 | 5.239 |
| September 12, 2024 | 5.120 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.119
Minimum
Oct 23 2024
14.40
Maximum
Dec 27 2023
8.220
Average
7.601
Median
Price to Book Value Benchmarks
| Bristol-Myers Squibb Co | 6.891 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
Price to Book Value Related Metrics
| PE Ratio | 20.76 |
| PS Ratio | 2.892 |
| Price to Free Cash Flow | 13.26 |
| Price | 16.20 |
| Earnings Yield | 4.82% |
| Market Cap | 2.695B |
| Operating PE Ratio | 23.95 |
| Normalized PE Ratio | 20.76 |